USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Simply Wall St.07-26

As you might know, USANA Health Sciences, Inc. (NYSE:USNA) last week released its latest second-quarter, and things did not turn out so great for shareholders. USANA Health Sciences missed ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2454379734?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345","is_english":true,"pubTime":"2024-07-26 18:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2454379734","market":"nz","top_or_hot":-1,"title":"USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now","media":"Simply Wall St.","content":"<div>\n<p>As you might know, USANA Health Sciences, Inc. (NYSE:USNA) last week released its latest second-quarter, and things did not turn out so great for shareholders.      USANA Health Sciences missed ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/household/nyse-usna/usana-health-sciences/news/usana-health-sciences-inc-earnings-missed-analyst-estimates\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUSANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-26 18:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/household/nyse-usna/usana-health-sciences/news/usana-health-sciences-inc-earnings-missed-analyst-estimates><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As you might know, USANA Health Sciences, Inc. (NYSE:USNA) last week released its latest second-quarter, and things did not turn out so great for shareholders.      USANA Health Sciences missed ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/household/nyse-usna/usana-health-sciences/news/usana-health-sciences-inc-earnings-missed-analyst-estimates\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"USNA","symbol_name":"优莎娜","start_time":0,"source_url":"https://simplywall.st/stocks/us/household/nyse-usna/usana-health-sciences/news/usana-health-sciences-inc-earnings-missed-analyst-estimates","article_id":"2454379734","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2454379734","pubTimestamp":1721988678,"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"As you might know, USANA Health Sciences, Inc. ( NYSE:USNA ) last week released its latest second-quarter, and things...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"USNA":"优莎娜"},"translate_title":"USANA Health Sciences,Inc.盈利未达分析师预期：以下是分析师现在的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":0.9},"content_text":"As you might know, USANA Health Sciences, Inc. (NYSE:USNA) last week released its latest second-quarter, and things did not turn out so great for shareholders.      USANA Health Sciences missed earnings this time around, with US$213m revenue coming in 3.7% below what the analysts had modelled. Statutory earnings per share (EPS) of US$0.54 also fell short of expectations by 17%.     Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual.  Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on USANA Health Sciences after the latest results.   View our latest analysis for USANA Health Sciences NYSE:USNA Earnings and Revenue Growth July 26th 2024 Following last week's earnings report, USANA Health Sciences' twin analysts are forecasting 2024 revenues to be US$862.3m, approximately in line with the last 12 months.       Statutory earnings per share are forecast to drop 14% to US$2.50 in the same period.        Before this earnings report, the analysts had been forecasting revenues of US$883.7m and earnings per share (EPS) of US$2.78 in 2024.        The analysts seem less optimistic after the recent results, reducing their revenue forecasts and making a substantial drop in earnings per share numbers.      It'll come as no surprise then, to learn that the analysts have cut their price target 14% to US$48.00.         Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates.      We would also point out that the forecast 2.9% annualised revenue decline to the end of 2024 is better than the historical trend, which saw revenues shrink 4.3% annually over the past five years   By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 6.5% per year.  So it's pretty clear that, while it does have declining revenues, the analysts also expect USANA Health Sciences to suffer worse than the wider industry.     The Bottom Line  The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for USANA Health Sciences.        Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business.       The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of USANA Health Sciences' future valuation.   Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings.   At least one analyst has provided forecasts out to 2025, which can be seen for free  on our platform here.  Don't forget that there may still be risks. For instance, we've identified   2 warning signs for USANA Health Sciences (1 doesn't sit too well with us)  you should be aware of.  New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2454379734"}